Scientists probe the mysteries of itch and pain in healthy volunteers
NCT ID NCT07255092
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aims to understand how people perceive itch and pain, including the effects of placebo and nocebo. Thirty healthy adults will have small areas of their forearms treated with substances that cause itching, then rate their sensations. The goal is to learn more about the body's itch and pain receptors, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 30 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * 18-60 years * Speak and understand English Exclusion Criteria: * Pregnancy or lactation * Drug addiction defined as any use of cannabis, opioids, or other drugs * Previous or current history of neurological, immunological, musculoskeletal, cardiac disorder or psychiatric diagnoses that may affect the results (e.g., neuropathy, muscular pain in the upper extremities, anxiety, depression, schizophrenia, etc.) * Moles, wounds, scars, or tattoos in the area to be treated or tested * Current use of medications that may affect the trial such as antihistamines and pain killers * Skin diseases * Consumption of alcohol or painkillers 24 hours before the study days and between these * Acute or chronic pain and itch * Participation in other trials within 1 week of study entry (4 weeks in the case of pharmaceutical studies) * Contraindications to capsaicin, including intolerance to chili or burns or wounds at the application site * The subject is assessed as unable to engage in the necessary cooperation required by the study
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Itch are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The places running it
1 site. The list below names each one and where it is.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
Contacts and locations
Locations
-
Aalborg University
Gistrup, Denmark, 9620, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Scientists launch study to unravel mysterious chronic itch
- New gel promises Ultra-Fast itch relief in seconds
- New cream targets itch in eczema patients
- Scientists heat up itch research to uncover how skin and brain talk
- Scientists probe itch and pain mysteries with histamine and cowhage
- Scientists probe pain and itch mysteries in healthy volunteers